梅尼耶氏病管理趋势:一个TriNetX网络数据库分析分析
Tyler J Gallagher1, Meredith E Adams2, Janet S Choi3
1Keck School of Medicine of the University of Southern California Los Angeles California USA.
OTO open
|March 15, 2024
概括
管理Meniere的管理.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 梅尼耶氏病 (Meniere's disease,简称MD) 是一种慢性内耳疾病.
- 了解MD管理的时间趋势对于优化患者护理至关重要.
研究的目的:
- 调查梅尼尔氏病管理实践中的时间趋势.
- 分析从2008年到2022年的药物,内内射和手术干预的变化.
主要方法:
- 使用TrinetX网络数据库的回顾性队列研究 (n=77,493名患者).
- 对MD诊断和管理代码的分析 (ICD-10,CPT,RXNorm).
- 结点回归用于分析时间趋势.
主要成果:
- 针对梅尼尔病的相关药物的处方显著增加 (APC: 1.2%).
- 内注射的速率没有显著变化.
- 内淋巴囊手术 (-8.1%的APC) 和迷宫切除术 (-11.0%的APC) 的发生率显著下降.
结论:
- 梅尼尔病的早期治疗越来越多地涉及药物治疗.
- 在研究期间,Meniere病的手术治疗率有所下降.
更多相关视频
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
648
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
648
Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Rheumatic Heart Disease III: Medical Management
548
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
548
Nephrotic Syndrome II : Assessment and Medical Management
422
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
422
Nephrotic Syndrome III : Nursing Management
558
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
558


